Granata Bio

Overview

Granata Bio is a biopharmaceutical company based in the U.S., founded in 2018, that specializes in women's health, particularly in infertility and reproductive health. The company is dedicated to identifying, in-licensing, and developing innovative fertility therapeutics to meet the needs of the reproductive health market in North America. With a team that has over 75 years of combined experience in clinical development and regulatory affairs, the organization focuses on ensuring safety, efficacy, and compliance in its therapeutic offerings.

Core activities include the development and commercialization of fertility therapeutics that support the entire IVF treatment cycle, from ovarian stimulation to luteal phase support. A notable advancement is the acquisition of Oviva Therapeutics, which introduced OVI-586, a novel therapeutic candidate aimed at addressing ovarian aging. Strategic partnership with Gedeon Richter Plc. enhances market presence and co-development of fertility products for the U.S. The organization is committed to improving patient experiences and clinical outcomes in the rapidly evolving field of reproductive health.

Basic Information

Contact Details

• Phone: +1 617-620-2640
• Website: granata.bio
• LinkedIn: linkedin.com/company/granatabio

Key Focus Areas & Initiatives

• Biotechnology research
• Clinical trial partnerships
• Fertility product licensing
• Therapeutics
• Regulatory affairs
• Infertility
• Patient access
• Safety evaluation
• Reproductive medicine innovation
• Pharmaceuticals
• Medical innovation
• Women's health
• Clinical trials
• Medications licensing
• Medical research
• Luteal phase support
• FDA-approved products
• Fertility medications
• Fertility treatment affordability
• Clinical development
• North America
• Biopharma
• Strategic partnerships
• Market growth
• Biotech collaboration
• IVF medications
• Drug licensing
• Patient advocacy
• Product commercialization
• Biotechnology
• Fertility treatments
• Clinical efficacy
• Regulatory compliance
• Women's reproductive health
• Market expansion
• Fertility drug development
• Reproductive health
• Fertility market
• Healthcare
• Product development
• Fertility treatment access
• Ovarian stimulation
• Fertility drug pipeline
• Healthcare innovation
• B2B
• Pharmaceutical and medicine manufacturing
• Patient care
• Medical
• Health care
• Health, wellness & fitness
• Hospital & health care

Technologies Used

• AI
• Amazon AWS
• Android
• Basis
• Gmail
• Google Apps
• Google Font API
• Google Maps
• Gusto
• IoT
• Mobile Friendly
• NSOne
• Outlook
• QuickBooks
• Remote
• Salesforce
• SharePoint
• Shutterstock
• Squarespace ECommerce
• Typekit

Affiliated Organizations & Regional Branches

• Oviva Therapeutics